Skip to main content

BRIEF-Biospecifics Technologies reports Q3 earnings per share $0.42

* Biospecifics Technologies Corp - total revenue for Q3 ended September 30, 2016 was $6.9 million, compared to $6.3 million
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.